A recent scoping review of anti-hypoglycaemic strategies demonstrated no differences in the prevalence of hypoglycaemia when comparing insulin dose (<10 units vs ≥10 units), rate of insulin administration (continuous vs bolus), type of insulin (regular vs short-acting) or timing of insulin administration relative to dextrose.1 The gene discussed is INS; the disease is Hypoglycemia.